Expression of nm23 in the spectrum of pre-invasive, invasive and metastatic breast lesions

Diagnostic Pathology

Volumn 3, Issue 1, 2008, Pages

  Bal, Amanjit ^a   Joshi, Kusum ^a   Logasundaram, Rajesh ^a   Radotra, B D ^a   Singh, Rajinder ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44949238509     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-3-23     Document Type: Article

References (29)

1. Changing trends-An overview of breast cancer incidence and mortality. L Garfinkel CC Boring CW Health, Cancer 1994 74 suppl 222 27
2. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. SR Welling HM Jensen RG Marcum, J Natl Cancer Inst 1975 155 2 231 73
3. Permalignant breast lesions: role for biological makers in predicting progression to cancer. BA Stoll, Eur J Cancer 1999 35 693 97 10.1016/S0959-8049(99)00026-X 10505026
4. Genetic analysis of 53 lymph-node negative breast carcinoma by CGH and relation to clinical, pathological, morphometric and DNA cytometric prognostic factors. MAJA Hermsen JPA Baak GA Meijer JM Weiss JWW Walboomers PJF Snijders PJV Duet, Pathol 1998 186 356 62 10.1002/(SICI)1096-9896(199812)186:4<356:: AID-PATH196>3.0.CO;2-Z
5. Editorial: Genetic control of Cancer metastasis. IJ Fidler R Radinsky, J Natl Cancer Inst 1990 82 166 68 10.1093/jnci/82.3.166 2296042
6. Genetic basis for metastasis. CW Evans, Cell Biol Int Rep 1991 15 1175 81 10.1016/0309-1651(91)90089-2 1802402
7. Evidence for a novel gene associated with low tumor metastatic potential. PS Steeg G Bevilacqua L Kopper UP Thorgeirsson JE Talmadge LA Liotta ME Sobel, J Natl Cancer Inst 1998 80 3 200 10.1093/jnci/80.3.200
8. The potential role of nm23 in cancer metastasis and cellular differentiation. NJ Mac Donald A De La Rosa PS Steeg, Eur J Cancer 1995 31A 1096 100 10.1016/0959-8049(95)00152-9 7576999
9. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinoma with lymph-node involvement and other histopathological indicators of high metastatic potential. G Bevilacqua ME Sobel LA Liotla PS Steeg, Cancer Res 1989 49 5185 90 2475243
10. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. T Nakayama A Ohtsuru K Nakao M Shima K Nakata K Watanabe N Ishii N Kimura S Nagataki, J Natl Cancer Inst 1992 84 1349 54 10.1093/jnci/84.17.1349 1322996
11. Expression of metastasis related nm23-H1 and nm23-H2 gene in ovarian carcinomas: correlation with clinicopathology, EGFR, C-erb B-2 and C-erb B-3 gene and sex steroid receptor expression. M Mandai I Konishi M Kashiyama T Mori S Arao H Tashiro H Okamura H Nomura H Hiai M Fukumoto, Cancer Res 1994 54 1825 30 7907945
12. High levels of nm23 expression are related to cell proliferation in human prostate cancer. M lgawa DB Ruskstalis T Tanabe, Cancer Res 1994 54 1313 18 8118821
13. High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous cell lung carcinoma are associated with poor differentiation and advanced tumor stages. M Engel B Theisinger T Seib, Int J Cancer 1993 55 375 79 10.1002/ijc.2910550306 8375920
14. The transition from hyperplasia to invasive carcinoma breast. SR Lakhani, J Pathol 1999 187 272 78 10.1002/(SICI)1096-9896(199902)187:3<272::AID- PATH265>3.0.CO;2-2 10398078
15. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. DL Page LW Rogers, Hum Pathol 1992 23 1095 97 10.1016/0046-8177(92)90026-Y 1328030
16. Loss of heterozygosity in lobular carcinoma in situ of the breast. SR Lakhani N Collins JP Sloane MR Stratton, Clin Mol Pathol 1995 48 2 M74 78 16695985 10.1136/mp.48.2.M74
17. Risk factors for breast cancer in women with proliferative breast disease. WD Dupont DL Page, N Engl J Med 1985 312 146 51 3965932
18. Premalignant conditions and markers of elevated risk in breast cancer and their management. DL Page WD Dupont, Surg Clin North Am 1990 70 831 51 2371647
19. Immunophenotypic and prognostic analysis of E-Cadherin and B Catenin expression during breast carcinogenesis and tumor progression a comparative study with CD44. A Bankfalvi HJ Terpe D Breukelmann, Histopathology 1999 34 25 34 10.1046/j.1365-2559.1999.00540.x 9934581
20. Analysis of oncogenes and tumor suppressor genes in human breast cancer. H Yamashita S Kobasyashi H Lwase Y Itoh T Kuzushima H Iwata K Itoh A Naito I Yamashita A Masaoka, Jpn J Cancer Res 1993 84 871 78 8104920
21. Reduced expression of nm23 H1, but not nm23 H2, is concordant with the frequency of lymph node metastasis of human breast cancer. Y Tokunaga T Urano K Furokawa H Kondo T Kanamatsu II Shiku, Int J Cancer 1993 55 66 71 10.1002/ijc.2910550113 8102131
22. Overexpression of nucleoside diphosphate kinase (nm23) in solid tumors. ML Lacombe X Sastre-Garau I Lascu A Vonica V Wallet JP Thiery Ml Véron, Eur J Cancer 1991 27 1302 07 1659843
23. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. N Hailat DR Keim RF Melhem XX Zhu C Eckerskorn GM Brodeur CP Reynolds RC Seeger F Lottspeich JR Strahler, J Clin Invest 1991 88 1 341 45 2056128 10.1172/JCI115299
24. Nm23 protein expression in ductal in situ and invasive human breast carcinoma. JA Royds TJ Stephenson RC Rees AJ Shorthouse PB Silcocks, J Natl Cancer Inst 1993 85 9 727 31 10.1093/jnci/85.9.727 8386774
25. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma. Z Gatalica SM Lele BA Rampy BA Norris, Cancer 2000 88 15 1378 83 10.1002/(SICI)1097-0142(20000315)88:6<1378: :AID-CNCR15>3.0.CO;2-I 10717620
26. Breast cancer metastasis-associated genes: role in tumor progression to the metastatic state. GL Nicolson, Biochem Soc Symp 1998 63 231 43 9513727
27. Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery. MJ Yunes AC Neuschatz LE Bornstein SP Naber V Band DE Wazer, Int J Radiat Oncol Biol Phys 56 3 653 57 2003 Jul 1 10.1016/S0360-3016(03) 00068-3 12788170
28. Expression and regulation of tumor suppressor gene maspin in breast cancer. N Maass K Nagasaki M Ziebart C Mundhenke W Jonat, Clin Breast Cancer 2002 3 281 87 12425757
29. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma. Y Umekita H Yoshida, Histopathology 2003 42 541 45 10.1046/j.1365-2559.2003.01620.x 12786889